Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models
出版年份 2013 全文链接
标题
Enhancing Hit Identification in Mycobacterium tuberculosis Drug Discovery Using Validated Dual-Event Bayesian Models
作者
关键词
Mycobacterium tuberculosis, Cytotoxicity, Library screening, Tuberculosis drug discovery, Tuberculosis, Kinase inhibitors, Machine learning, Drug discovery
出版物
PLoS One
Volume 8, Issue 5, Pages e63240
出版商
Public Library of Science (PLoS)
发表日期
2013-05-08
DOI
10.1371/journal.pone.0063240
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Bayesian Models Leveraging Bioactivity and Cytotoxicity Information for Drug Discovery
- (2013) Sean Ekins et al. CHEMISTRY & BIOLOGY
- MDR-TB Has New Drug Foe After Fast-Track Approval
- (2013) Rebecca Voelker JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Identification of Novel Inhibitors of M. tuberculosis Growth Using Whole Cell Based High-Throughput Screening
- (2012) Sarah A. Stanley et al. ACS Chemical Biology
- A High-Throughput Screen To Identify Inhibitors of ATP Homeostasis in Non-replicating Mycobacterium tuberculosis
- (2012) Puiying A. Mak et al. ACS Chemical Biology
- Substituted aminopyrimidine protein kinase B (PknB) inhibitors show activity against Mycobacterium tuberculosis
- (2012) Timothy M. Chapman et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Recognizing Pitfalls in Virtual Screening: A Critical Review
- (2012) Thomas Scior et al. Journal of Chemical Information and Modeling
- QSAR Classification Model for Antibacterial Compounds and Its Use in Virtual Screening
- (2012) Narender Singh et al. Journal of Chemical Information and Modeling
- Abelson Tyrosine Kinase Controls Phagosomal Acidification Required for Killing of Mycobacterium tuberculosis in Human Macrophages
- (2012) H. Bruns et al. JOURNAL OF IMMUNOLOGY
- Risk of Tuberculosis Reactivation With Tofacitinib (CP-690550)
- (2012) Mamoudou Maiga et al. JOURNAL OF INFECTIOUS DISEASES
- Structure of the Sensor Domain of Mycobacterium tuberculosis PknH Receptor Kinase Reveals a Conserved Binding Cleft
- (2012) Alexandra Cavazos et al. JOURNAL OF MOLECULAR BIOLOGY
- Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study
- (2012) Tracy Dalton et al. LANCET
- Combining Cheminformatics Methods and Pathway Analysis to Identify Molecules with Whole-Cell Activity Against Mycobacterium Tuberculosis
- (2012) Malabika Sarker et al. PHARMACEUTICAL RESEARCH
- Nonsteroidal anti-inflammatory drug sensitizes Mycobacterium tuberculosis to endogenous and exogenous antimicrobials
- (2012) B. Gold et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- VEGF and c-Met Blockade Amplify Angiogenesis Inhibition in Pancreatic Islet Cancer
- (2011) W.-K. You et al. CANCER RESEARCH
- Imatinib-Sensitive Tyrosine Kinases Regulate Mycobacterial Pathogenesis and Represent Therapeutic Targets against Tuberculosis
- (2011) Ruth J. Napier et al. Cell Host & Microbe
- In silico repositioning of approved drugs for rare and neglected diseases
- (2011) Sean Ekins et al. DRUG DISCOVERY TODAY
- Challenges and opportunities in developing novel drugs for TB
- (2011) Takushi Kaneko et al. Future Medicinal Chemistry
- A Machine Learning-Based Method To Improve Docking Scoring Functions and Its Application to Drug Repurposing
- (2011) Sarah L. Kinnings et al. Journal of Chemical Information and Modeling
- Synthesis and Structure–Activity Relationships of Varied Ether Linker Analogues of the Antitubercular Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2011) Andrew M. Thompson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Structure–Activity Relationships for Amide-, Carbamate-, And Urea-Linked Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2011) Adrian Blaser et al. JOURNAL OF MEDICINAL CHEMISTRY
- The challenge of new drug discovery for tuberculosis
- (2011) Anil Koul et al. NATURE
- Impact of high-throughput screening in biomedical research
- (2011) Ricardo Macarron et al. NATURE REVIEWS DRUG DISCOVERY
- Finding Promiscuous Old Drugs for New Uses
- (2011) Sean Ekins et al. PHARMACEUTICAL RESEARCH
- High throughput screening of a library based on kinase inhibitor scaffolds against Mycobacterium tuberculosis H37Rv
- (2011) Robert C. Reynolds et al. TUBERCULOSIS
- A collaborative database and computational models for tuberculosis drug discovery
- (2010) Sean Ekins et al. Molecular BioSystems
- Virtual screening: an endless staircase?
- (2010) Gisbert Schneider NATURE REVIEWS DRUG DISCOVERY
- Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery
- (2010) Sean Ekins et al. TRENDS IN MICROBIOLOGY
- Leads for antitubercular compounds from kinase inhibitor library screens
- (2010) Sophie Magnet et al. TUBERCULOSIS
- Inhibition of Tumor Cell Growth, Invasion, and Metastasis by EXEL-2880 (XL880, GSK1363089), a Novel Inhibitor of HGF and VEGF Receptor Tyrosine Kinases
- (2009) F. Qian et al. CANCER RESEARCH
- Signaling mechanisms of the Mycobacterium tuberculosis receptor Ser/Thr protein kinases
- (2009) Tom Alber CURRENT OPINION IN STRUCTURAL BIOLOGY
- Novel web-based tools combining chemistry informatics, biology and social networks for drug discovery
- (2009) Moses Hohman et al. DRUG DISCOVERY TODAY
- Synthesis and Structure−Activity Studies of Biphenyl Analogues of the Tuberculosis Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2009) Brian D. Palmer et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design of novel antituberculosis compounds using graph-theoretical and substructural approaches
- (2009) Alejandro Speck Planche et al. MOLECULAR DIVERSITY
- Repurposing libraries of eukaryotic protein kinase inhibitors for antibiotic discovery
- (2009) Christopher T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Antituberculosis activity of the molecular libraries screening center network library
- (2009) Joseph A. Maddry et al. TUBERCULOSIS
- High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv
- (2009) Subramaniam Ananthan et al. TUBERCULOSIS
- Global Bayesian Models for the Prioritization of Antitubercular Agents
- (2008) Philip Prathipati et al. Journal of Chemical Information and Modeling
- Discovery of Novel Nitrobenzothiazole Inhibitors forMycobacterium tuberculosisATP Phosphoribosyl Transferase (HisG) through Virtual Screening
- (2008) Yoonsang Cho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Synthesis, Reduction Potentials, and Antitubercular Activity of Ring A/B Analogues of the Bioreductive Drug (6S)-2-Nitro-6-{[4-(trifluoromethoxy)benzyl]oxy}-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazine (PA-824)
- (2008) Andrew M. Thompson et al. JOURNAL OF MEDICINAL CHEMISTRY
- Rising standards for tuberculosis drug development
- (2008) Tanjore S. Balganesh et al. TRENDS IN PHARMACOLOGICAL SCIENCES
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started